title: Difficult-to-detect carbapenem-resistant IMP13-producing P. aeruginosa: experience feedback concerning a cluster of urinary tract infections at a surgical clinic in France.
abstract: BACKGROUND
  We report a carbapenem-resistant P. aeruginosa clone responsible for a cluster of urinary tract infections in elderly surgery patients, diagnosed during a three-month period in a 59-bed surgical clinic.
  
  
  RESULTS
  The clonal nature of the cluster was established by molecular study of the P. aeruginosa isolates (PFGE and MLST). Despite an MIC of imipenem in the susceptibility range for two isolates, all were metallo-β-lactamase-producers (IMP13-type, clone ST621). We conducted a review of the medical and surgical procedures. We tested water delivered into the clinic and urological devices for the presence of the epidemic strain. The hygiene nurse observed hygiene practices. A week after the implementation of barrier precautions around the fourth infected patient, we studied the extent to which the patients hospitalised were colonised to assess whether the spread of the epidemic strain had been controlled.
  
  
  CONCLUSIONS
  1/ Our findings indicate the difficulties in the detection of the metallo-β-lactamase in this clone, that resulted in the alert being delayed. 2/ Unlike most investigations of UTI outbreaks described in urology wards, we did not detect any contaminated urological devices or water colonisation. 3/ Consistent with outbreaks involving the IMP-13 clone in critical care units, the observation of inadequate application of standard precautions argued for patient-to-patient transmission during urinary management of the urology patients. 4/ The implementation of barrier precautions around infected patients resulted in control of the spread of the epidemic clone. This report serves as an alert concerning a difficult-to-detect multidrug-resistant P. aeruginosa clone in elderly urology patients.
authors.affiliation: Service de Bactériologie et Hygiène, Tours, France. n.vandermee@chu-tours.fr.
authors.forename: Odile
authors.initials: O
authors.lastname: Milan
authors.forename: Laurent
authors.initials: L
authors.lastname: Debroize
authors.forename: Xavier
authors.initials: X
authors.lastname: Bertrand
authors.forename: Patrick
authors.initials: P
authors.lastname: Plesiat
authors.forename: Anne-Sophie
authors.initials: AS
authors.lastname: Valentin
authors.forename: Roland
authors.initials: R
authors.lastname: Quentin
authors.forename: Nathalie
authors.initials: N
authors.lastname: Van der Mee-Marquet
references.citation: J Antimicrob Chemother. 2011 Sep;66(9):2178-9
references.pmid: 21693463
references.citation: J Hosp Infect. 2010 Apr;74(4):350-7
references.pmid: 20170982
references.citation: J Hosp Infect. 1998 Aug;39(4):301-7
references.pmid: 9749401
references.citation: Clin Microbiol Infect. 2011 Aug;17(8):1272-5
references.pmid: 21375657
references.citation: J Antimicrob Chemother. 2003 Oct;52(4):583-90
references.pmid: 12951335
references.citation: Am J Infect Control. 2012 Nov;40(9):854-9
references.pmid: 22325732
references.citation: J Clin Microbiol. 2011 Jan;49(1):263-8
references.pmid: 21084517
references.citation: Int J Antimicrob Agents. 2012 Dec;40(6):571-3
references.pmid: 23089049
references.citation: J Urol. 2008 Aug;180(2):588-92; discussion 592
references.pmid: 18554660
references.citation: J Clin Microbiol. 2010 Nov;48(11):4342-3
references.pmid: 20844220
references.citation: Rev Argent Microbiol. 2008 Oct-Dec;40(4):238-45
references.pmid: 19213249
references.citation: Infect Control Hosp Epidemiol. 2011 Dec;32(12):1179-86
references.pmid: 22080656